The minimum expect value was set 10 with gap penalties existence 11 and extension 1 for. BLAST similarity search. To find true homology, we have used BLOSUM62 substitution matrix.
We have found, out of 14633 proteins of C. albicans, 4568 proteins resulted unique or essential to Candida and not showed any similarity with Human proteome. Similarly 2955 proteins resulted unique against S. cerevisiae (Fig. 1) .
Further unique proteins have been categorized into three major classes-annotated, hypothetical and uncharacterized ORF/unknown (Table 1) .
Results showed that like proteome of C. albicans which comprises 72.44% hypothetical protein, predicted unique proteins of Candida against Human and S. cerevisiae indicate higher ratio of hypothetical proteins viz., 86.56%and 92.45% respectively.
Results showed that large number of unique proteins are still uncharacterized & unexplored functionally. Most of the unique proteins predicted functionally unknown or uncharacterized ORF . Annotated or known unique proteins were classified into different functional class of drug targets ( Table 2) . Most of the unique proteins were classified under enzyme category followed by transcription factors, transporters and receptor (Table 2) . Figure 2 Candida albicans, an opportunistic flora inhabitant of human gastrointestinal tract with no pathogenic consequence in healthy people. However, it causes severe mucosal infection and sometimes systemic infection leading to candidiasis in immunocompromised patient. Development of antifungal resistance adding more concern and render us to find novel and potential antifungal targets that could lead to develop effective antifungal drug. Existing way to identify potential targets rely on specific subsets like virulence genes, species-specific genes, uncharacterized essential genes, unique enzymes, membrane transporters etc (Galperin and Koonin, 1999). However, comparative genomics approach uses genome wide screening of potential targets including all functional categories. More precisely, these can be further classified into different groups like enzyme, transporter, receptor, transcription factors etc. In the present study, we have used comparative genomics approach to identify novel drug targets in C. albicans. We have analyzed 14,633 proteins of C. albicans proteome and after comparison with human proteome, we have predicted 4,568 unique proteins. The proteins of C. albicans not showing significant homology to human and S. cerevisiae proteomes were termed as unique proteins. Predicted as well as experimental data have been compiled in the form of CaTargetDB database which is accessible at LAN of CIMAP. 
Additionally we have elucidated domain, motif and family of predicted unique/essential proteins of Candida by using CDD (NCBI), PROSITE, Pfam databases. All the predicted results as well as experimental data have been compiled in to database named 'CaTargetDB', available at CIMAP local network (LAN). Snap shots are shown in
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